Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03110354
Title DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Inc.
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

Therapies

DS-3201b

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02115 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Durham North Carolina 27710 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field